393 Results

People

  1. Perales
    Perales
  2. Giralt
    Giralt
  3. Shouval
    Shouval
  4. Shah
    Shah
  5. Nelson
    Nelson
  6. Park
    Park
  7. Scordo
    Scordo
  8. Dahi
    Dahi
  9. Jones
    Jones
  10. Mehrara
    Mehrara

Groups

  1. Department of Medicine (175)
  2. Surgery (101)
  3. Survivorship Research (98)
  4. Hematologic Malignancies, Division of (92)
  5. Center for Hematologic Malignancies (78)
  6. Sloan Kettering Institute Postdocs (66)
  7. Solid Tumor Oncology Division (66)
  8. Population Sciences Research Program (60)
  9. Division of Subspecialty Medicine (57)
  10. Epidemiology and Biostatistics (57)
  1. "adverse event"
Formats
  1. Journal Article (266)
  2. Review (75)
  3. Editorial (17)
  4. Guidelines (11)
  5. Research Letter (11)
  6. Correspondence (8)
  7. Conference Paper (2)
  8. Miscellaneous (2)
  9. Meeting Abstract (1)
Groups
  1. Department of Medicine (175)
  2. Surgery (101)
  3. Survivorship Research (98)
  4. Hematologic Malignancies, Division of (92)
  5. Center for Hematologic Malignancies (78)
  6. Sloan Kettering Institute Postdocs (66)

More Groups

People
  1. Miguel-Angel Perales (32)
  2. Sergio Giralt (20)
  3. Sean Devlin (17)
  4. Jonas Nelson (14)
  5. Roni Shouval (13)
  6. Gunjan Shah (12)

More People

Years
  1. 2025 (62)
  2. 2024 (100)
  3. 2023 (62)
  4. 2022 (106)
  5. 2021 (15)
  6. 2020 (17)

More Years

Publications
  1. Transplantation and Cellular Therapy (26)
  2. Journal of Clinical Oncology (17)
  3. Clinical Cancer Research (11)
  4. International Journal of Radiation Oncology, Biology, Physics (11)
  5. Annals of Surgical Oncology (10)
  6. Plastic and Reconstructive Surgery (10)

More Publications

Publishers
  1. Elsevier Inc. (76)
  2. Springer (39)
  3. Elsevier Science, Inc. (34)
  4. Nature Publishing Group (25)
  5. Lippincott Williams & Wilkins (23)
  6. American Society of Clinical Oncology (18)

More Publishers

Results (393)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Management of immune-related adverse events in patients treated with chimeric antigen receptor T-cell therapy: ASCO guideline
    Guidelines

    Santomasso, B. D.; Nastoupil, L. J.; Adkins, S.; Lacchetti, C.; Schneider, B. J.; Anadkat, M.; Atkins, M. B.; Brassil, K. J.; Caterino, J. M.; Chau, I.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Risk factors for adverse events in patients with breast, colorectal, and lung cancer
    Journal Article

    Weingart, S. N.; Atoria, C. L.; Pfister, D.; Classen, D.; Killen, A.; Fortier, E.; Epstein, A. S.; Anderson, C.; Lipitz-Snyderman, A.
    Journal of Patient Safety (2021)

    Fulltext@MSK | Save
  • Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067
    Journal Article

    Regan, M. M.; Mantia, C. M.; Werner, L.; Tarhini, A. A.; Larkin, J.; Hodi, F. S.; Wolchok, J.; Postow, M. A.; Stwalley, B.; Moshyk, A.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation
    Journal Article

    Mou, E.; Falchi, L.; Sundaram, V.; Abramson, J. S.; Balassanian, R.; Beygi, S.; Fitzpatrick, M. J.; Frank, A. K.; Gupta, S.; Lin, O.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Early use of high-dose glucocorticoid for the management of irAE is associated with poorer survival in patients with advanced melanoma treated with anti-PD-1 monotherapy
    Journal Article

    Bai, X.; Hu, J.; Betof Warner, A.; Quach, H. T.; Cann, C. G.; Zhang, M. Z.; Si, L.; Tang, B.; Cui, C.; Yang, X.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Understanding adverse events related to perioperative immunotherapy: A primer for thoracic surgeons
    Editorial

    Jones, D. R.
    Thoracic Cancer (2021)

    Fulltext@MSK | Save
  • The duration of antibiotics prophylaxis at the time of catheter removal after radical prostatectomy: Clinically integrated, cluster, randomized trial
    Journal Article

    Ehdaie, B.; Jibara, G.; Sjoberg, D. D.; Laudone, V.; Eastham, J.; Touijer, K.; Scardino, P.; Donahue, T.; Goh, A.; Vickers, A.
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • An antibody against L1 cell adhesion molecule inhibits cardiotoxicity by regulating persistent DNA damage
    Journal Article

    Nam, J. K.; Kim, A. R.; Choi, S. H.; Kim, J. H.; Choi, K. J.; Cho, S.; Lee, J. W.; Cho, H. J.; Kwon, Y. W.; Cho, J.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: A multicentre, retrospective, cohort study
    Journal Article

    Pires da Silva, I.; Ahmed, T.; Reijers, I. L. M.; Weppler, A. M.; Betof Warner, A.; Patrinely, J. R.; Serra-Bellver, P.; Allayous, C.; Mangana, J.; Nguyen, K.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies
    Journal Article

    Shaw, J. L.; Nielson, C. M.; Park, J. K.; Marongiu, A.; Soff, G. A.
    European Journal of Haematology (2021)

    Fulltext@MSK | Save